Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

404322

Sigma-Aldrich

Dichloro(1,2-diaminocyclohexane)platinum(II)

Sinonimo/i:

(1,2-Diaminocyclohexane)platinum(II) chloride

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula condensata:
[C6H10(NH2)2]PtCl2
Numero CAS:
52691-24-4
Peso molecolare:
380.17
Numero MDL:
MFCD00058826
Codice UNSPSC:
12161600
ID PubChem:
24865237
NACRES:
NA.22

Livello qualitativo

100

Impiego in reazioni chimiche

core: platinum
reagent type: catalyst

Punto di fusione

280 °C (dec.) (lit.)

Stringa SMILE

Cl[Pt]Cl.NC1CCCCC1N

InChI

1S/C6H14N2.2ClH.Pt/c7-5-3-1-2-4-6(5)8;;;/h5-6H,1-4,7-8H2;2*1H;/q;;;+2/p-2
PNNCIXRVXCLADM-UHFFFAOYSA-L

Pittogrammi

Health hazardCorrosion
GHS08,GHS05

Avvertenze

Danger

Classi di pericolo

Carc. 2 - Eye Dam. 1 - Lact. - Muta. 2 - Repr. 1B - Resp. Sens. 1B - Skin Sens. 1 - STOT RE 1

Codice della classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

Eyeshields, Gloves, type N95 (US)

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
MKCH0904
MKBX4372V
MKBS5387V
MKBD2991V
MKBL6276V

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 7

1 of 7

Oxaliplatin European Pharmacopoeia (EP) Reference Standard

Y0000271

Oxaliplatin

Oxaliplatin United States Pharmacopeia (USP) Reference Standard

USP

1481204

Oxaliplatin

(1R,2R)-(−)-1,2-Diaminocyclohexane 98%

Sigma-Aldrich

346721

(1R,2R)-(−)-1,2-Diaminocyclohexane

(±)-trans-1,2-Diaminocyclohexane 99%

Sigma-Aldrich

270016

(±)-trans-1,2-Diaminocyclohexane

Oxaliplatin powder

Sigma-Aldrich

O9512

Oxaliplatin

Dichloro(1,5-cyclooctadiene)platinum(II)

Sigma-Aldrich

244937

Dichloro(1,5-cyclooctadiene)platinum(II)

Potassium tetrachloroplatinate(II) 98%

Sigma-Aldrich

206075

Potassium tetrachloroplatinate(II)

V Boudný et al.
Nucleic acids research, 20(2), 267-272 (1992-01-25)
Modification of DNA and double-stranded deoxyoligonucleotides with antitumour 1,2-diamino-cyclohexanedinitroplatinum(II) (Pt-dach) complexes was investigated with the aid of physico-chemical methods and chemical probes of nucleic acid conformation. The three Pt-dach complexes were used which differed in isomeric forms of the dach
G R Gibbons et al.
Cancer research, 49(6), 1402-1407 (1989-03-15)
Tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) is a new platinum analogue which is less nephrotoxic than cisplatin and is effective in some cell lines which have become resistant to cisplatin. Since platinum(IV) compounds are thought to require reduction to their platinum(II) analogues for activity
H Cabral et al.
Nature nanotechnology, 6(12), 815-823 (2011-10-25)
A major goal in cancer research is to develop carriers that can deliver drugs effectively and without side effects. Liposomal and particulate carriers with diameters of ∼100 nm have been widely used to improve the distribution and tumour accumulation of cancer
Siden Top et al.
Chembiochem : a European journal of chemical biology, 4(8), 754-761 (2003-08-05)
The goal of our study was to potentiate the effects of the ((R,R)-trans-1,2-diaminocyclohexane)-platinum(II) fragment [(DACH)Pt], known for its cytotoxic properties, either with tamoxifen (Tam), the most widely used antiestrogen in the treatment of hormone-dependent breast cancers, or with its active
P F Carfagna et al.
Cancer chemotherapy and pharmacology, 27(5), 335-341 (1991-01-01)
Plasma biotransformations of tetrachloro(d,l-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) were determined in vivo at both therapeutic (3 mg/kg) and toxic (12 mg/kg) doses in Fischer 344 rats. Tetraplatin was rapidly converted to dichloro(d,l-trans)1,2-diaminocyclohexaneplatinum(II) [PtCl2(dach)]. This conversion was complete at the earliest time measured (7.5
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.